Cargando…

Identification and Validation of a Novel Multiomics Signature for Prognosis and Immunotherapy Response of Endometrial Carcinoma

PURPOSE: Cancer development and immune escape involve DNA methylation, copy number variation, and other molecular events. However, there are remarkably few studies integrating multiomics genetic profiles into endometrial cancer (EC). This study aimed to develop a multiomics signature for the prognos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Zhicheng, Wang, Qiu, Liu, Xiuqing, Zheng, Jiantong, Ji, Ling, Li, Xiaofeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587907/ https://www.ncbi.nlm.nih.gov/pubmed/36281289 http://dx.doi.org/10.1155/2022/8998493

Ejemplares similares

Integrated Bioinformatics Analysis for Identification of the Hub Genes Linked with Prognosis of Ovarian Cancer Patients
por: Li, Xiaofeng, et al.
Publicado: (2022)

Multiomics profiling of the expression and prognosis of MCMs in endometrial carcinoma
por: Lan, Hua, et al.
Publicado: (2021)

Identification and validation of a novel cuproptosis-related lncRNA signature for prognosis and immunotherapy of head and neck squamous cell carcinoma
por: Xu, Qiu-Shuang, et al.
Publicado: (2022)

Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Endometrial Carcinoma to Immunotherapy and Chemotherapy
por: Liu, Jinhui, et al.
Publicado: (2021)

Identification of an immune checkpoint gene signature that accurately predicts prognosis and immunotherapy response in endometrial carcinoma
por: Li, Shaowen, et al.
Publicado: (2021)

Multiomics Analysis Reveals Cuproptosis-Related Signature for Evaluating Prognosis and Immunotherapy Efficacy in Colorectal Cancer
por: He, Rong, et al.
Publicado: (2023)

Identification of inflammatory-related gene signatures to predict prognosis of endometrial carcinoma
por: Chen, Linlin, et al.
Publicado: (2022)

Multiomics profile and prognostic gene signature of m6A regulators in uterine corpus endometrial carcinoma
por: Wang, Yizi, et al.
Publicado: (2020)

Identification of the 11-lncRNA signatures associated with the prognosis of endometrial carcinoma
por: Wan, Jing, et al.
Publicado: (2021)

Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma
por: Zhou, Cankun, et al.
Publicado: (2020)

Identification and validation of a novel signature for prediction the prognosis and immunotherapy benefit in bladder cancer
por: Zhang, Yichi, et al.
Publicado: (2022)

Recent Multiomics Approaches in Endometrial Cancer
por: Boroń, Dariusz, et al.
Publicado: (2022)

Identification and validation a costimulatory molecule gene signature to predict the prognosis and immunotherapy response for hepatocellular carcinoma
por: Hu, Yinan, et al.
Publicado: (2022)

Identification and validation of a novel cuproptosis-related genes signature associated with prognosis, clinical implications and immunotherapy of hepatocellular carcinoma
por: He, Fengjiao, et al.
Publicado: (2023)

Identification of a Novel Epithelial–Mesenchymal Transition-Related Gene Signature for Endometrial Carcinoma Prognosis
por: Ruan, Tianyuan, et al.
Publicado: (2022)

Identification of cancer-associated fibroblasts signature for predicting the prognosis and immunotherapy response in hepatocellular carcinoma
por: Ye, Jianzhong, et al.
Publicado: (2023)

Identification and validation of a glycolysis-associated multiomics prognostic model for hepatocellular carcinoma
por: Deng, Tuo, et al.
Publicado: (2021)

Identification of immune-related gene signature for predicting prognosis in uterine corpus endometrial carcinoma
por: Song, Siyuan, et al.
Publicado: (2023)

Development and Validation of a Novel Ferroptosis-Related Gene Signature for Prognosis and Immunotherapy in Hepatocellular Carcinoma
por: Zhang, Bo, et al.
Publicado: (2022)

Multiomics Data Analysis and Identification of Immune-Related Prognostic Signatures With Potential Implications in Prognosis and Immune Checkpoint Blockade Therapy of Glioblastoma
por: Ma, Shuai, et al.
Publicado: (2022)

A multiomics comparison between endometrial cancer and serous ovarian cancer
por: Zhong, Hui, et al.
Publicado: (2020)

Identification and Validation of Cuproptosis-Related LncRNA Signatures in the Prognosis and Immunotherapy of Clear Cell Renal Cell Carcinoma Using Machine Learning
por: Bai, Zhixun, et al.
Publicado: (2022)

Construction and Validation of an Epigenetic Regulator Signature as A Novel Biomarker For Prognosis, Immunotherapy, And Chemotherapy In Hepatocellular Carcinoma
por: Cai, Jialiang, et al.
Publicado: (2022)

Identification of a five-gene signature for predicting the progression and prognosis of stage I endometrial carcinoma
por: Bian, Jia, et al.
Publicado: (2020)

Identification and validation of oxeiptosis-associated lncRNAs and prognosis-related signature genes to predict the immune status in uterine corpus endometrial carcinoma
por: Niu, Linjun, et al.
Publicado: (2023)

BTG1 inhibits malignancy as a novel prognosis signature in endometrial carcinoma
por: Li, Yibing, et al.
Publicado: (2020)

Identification of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and Responsiveness to Immunotherapy in Hepatocellular Carcinoma
por: Wang, Qingbin, et al.
Publicado: (2023)

Identification of an eleven-miRNA signature to predict the prognosis of endometrial cancer
por: Lu, Jing, et al.
Publicado: (2021)

Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis
por: Huang, Changjing, et al.
Publicado: (2021)

Identification of NAD(+) Metabolism-Derived Gene Signatures in Ovarian Cancer Prognosis and Immunotherapy
por: Lin, Liang, et al.
Publicado: (2022)

Identification and validation of tumor microenvironment-related signature for predicting prognosis and immunotherapy response in patients with lung adenocarcinoma
por: Li, Chunhong, et al.
Publicado: (2023)

Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Colon Cancer to Immunotherapy
por: Wang, Zheng, et al.
Publicado: (2022)

Identification of PANoptosis-Based Prognostic Signature for Predicting Efficacy of Immunotherapy and Chemotherapy in Hepatocellular Carcinoma
por: Xiong, Xiaofeng, et al.
Publicado: (2023)

Identification and validation of TNFRSF4 as a high-profile biomarker for prognosis and immunomodulation in endometrial carcinoma
por: Ma, Heng, et al.
Publicado: (2022)

Comprehensive analysis of PHGDH for predicting prognosis and immunotherapy response in patients with endometrial carcinoma
por: Zhang, He, et al.
Publicado: (2023)

Identification of methylation-driven genes prognosis signature and immune microenvironment in uterus corpus endometrial cancer
por: Liu, JinHui, et al.
Publicado: (2021)

Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis
por: Yan, Zongcai, et al.
Publicado: (2021)

Identification of EMT-Related Gene Signatures to Predict the Prognosis of Patients With Endometrial Cancer
por: Cai, Luya, et al.
Publicado: (2020)

Identification and Validation of Cuproptosis-Related Prognostic Signature and Associated Regulatory Axis in Uterine Corpus Endometrial Carcinoma
por: Chen, Yun
Publicado: (2022)

Identification and validation of an eight-lncRNA signature that predicts prognosis in patients with esophageal squamous cell carcinoma
por: Zhang, Jinfeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b2iis4nj8r4al7afeoadv6t9mt